Study Evaluating Treatment of Sacituzumab-govitecan for Patients With Metastatic Esophagogastric Adenocarcinoma
Clinical trial NCT06123468 · COMPLETED
Trial details
- NCT number
- NCT06123468
- Sponsor
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-17
- Primary completion
- 2026-01-07
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.